In vitro antimicrobial activity of Cryptolepis sanguinolenta (periplocaceae)

African Journal of Pharmacy and Pharmacology

Volumn 3, Issue 10, 2009, Pages 476-480

  Mills Robertson, Felix C ^a   Aboagye, Frederick A ^a   Duker Eshun, George ^a   Kaminta, Sylvester ^a   Agbeve, Samuel ^a  

^a Centre for Scientific Research Into Plant Medicine Ghana   (Ghana)

Author keywords

Antibacterial; Cryptolepis sanguinolenta; Periplocaceae

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; CRYPTOLEPIS SANGUINOLENTA EXTRACT; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; PLANT EXTRACT; TETRACYCLINE; TIOCONAZOLE; UNCLASSIFIED DRUG;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANDIDA ALBICANS; CONTROLLED STUDY; CRYPTOLEPIS; CRYPTOLEPIS SANGUINOLENTA; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

EID: 77953659077     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Addy M (2003). Cryptolepis: an African traditional medicine that provides hope for malaria victims. HerbalGram. 60: 54-59.
2. Bierer DE, Fort DM, Mendez CD, Luo J, Imbach PA, Dubenko LG, Jolad SD, Gerber RE, Litvak J, Lu Q, Zhang P, Reed MJ, Waldeck N, Bruening RC, Noames BK, Hector RF, Carlson TJ, King SR (1998). Ethnobotanical-directed discovery of the antihyperglycaemic properties of cryptolepine: Its isolation from Cryptolepis sanguinolenta, synthesis and in vitro and in vivo activities. J. Med. Chem. 41: 894-901.
3. Boakye-Yiadom K, Dwuma-Badu D (1977). "Proceedings of the 3rd symposium on African Medicinal Plants". University of Ife, Ife-Ife, Nigeria.
4. Boakye - Yiadom K, Heman - Ackah SM (1979). Cryptolepine hydrochloride action on Staphylococcus aureus. J. Pharmaceut. Sci. 68: 1510-1514.
5. Bonjean K, De Pauw-Gillet MC, Defresne MP, Colson P, Houssier C, Dassonneville L, Bailly C, Greimers R, Wright C, Quentin-Leclercq J, Tits M, Angenot L (1998). The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits the primarily DNA synthesis in B16 melanoma cells. Biochem. 37: 5136-5146. (Pubitemid 28176514)
6. Boye GL, Ampofo O (1983). Proceedings of the First International Symposium on cryptolepine. Abstract No. 4. University of Science and Technology, Kumasi, Ghana.
7. Ciulei I (1982). Methodology for analysis of vegetable drugs. In: Practical Manuals on Industrial Utilization of Medicinal and Aromatic plants. Edited by the Ministry of Chemical Industry, Bucharest p. 73.
8. Dassonnrville L, Lansiaux A, Wattelet A, Wattez N, Mathieu C, Van Miert S, Pieters L, Bailly C (2000). Cytotoxicity and cell cycle effect of the plant alkaloids cryptolepine and neocryptolepine: relation to druginduced apoptosis. Eur. J. Pharmacol. 409: 9-18.
9. Dokosi OB (1998). Herbs of Ghana. Ghana Universities Press, Accra
10. Dwuma-Badu D, Ayin JKS, Fiagbe NIY, Knapp JE, Shiff PL, Slatkin DJJ (1978). Quindoline from Cryptolepis sanguinolenta. J. Pharm. Sci. 67: 433-635.
11. Fennell CW, Lindsey KL, McGaw LJ, Sprag SG, Staffort GI, Elgorashi EE, Grace OM, van Staden J (2004). Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicity. J. Ethnopharmacol. 94: 205-217. (Pubitemid 39119923)
12. Fong EHS, Tin-Wa M, Farnsworth NR, Dobberstein RH (1977). Phytochemical Screening Methods. Department of Pharmacognosy and Pharmacology. College of Pharmacy, University of Illinois at the Medical Center. 833 South Wood Street, Chicago, Illinois 60612, USA.
13. Guittat L, Alberti P, Rosu F, Van MS, Thetiot E, Pieters L, Gabelica V, De Pauw E, Ottaviani A, Roiu JF, Mergny JL (2003). Interaction of cryptolepine and neocryptolepine with unusual DNA structures Biochem. 85: 535-541.
14. Http://medic.med.uth.tmc.edu/00001450.htm (2006). Evolution and transfer of antibiotic-resistant bacteria. CMAJ 159: 1129-1136.
15. Kirby GC, Paine A, Warhurst DC, Noamesi BK, Philipson JD (1995). In vitro and in vivo antimalarial activity of cryptolepine, a plant-derived indoquinoline. Phytother. Res. 9: 359-363.
16. Lisgarten JN, Coll M, Portugal J, Wright CW, Aymami J (2002). The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites. Nat. Struct. Biol. 9: 57-60.
17. NCCLS (1998). National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests Approved standard M2-A6. Wayne, PA, USA.
18. Noamesi BK, Paine A, Kirby GC, Warhurst DC Philipson GD (1991). In vitro antimalarial action of cryptolepine, an indoquinoline. Trans. R. Soc. Trop. Med. Hyg. 85: 315.
19. Paulo A, Houghton PJ (2003). Chemotaxonomic analysis of the genus Cryptolepis. Biochem. Syst. Ecol. 31: 155-166.
20. Sackey BA, Mensah P, Collison E, Sakyi-Dawson E (2001). Campylobacter, Salmonella, Shigella and Escherichia coli in live and dressed poultry from Metropolitan Accra. Int. J. Food. Microbiol. 71: 21-28.
21. Sawer IK, Berry MI, Ford JL (2005). The killing effect of cryptolepine on Staphylococcus aureus. Lett. Appl. Microbiol. 40(1): 24-29.
22. Tackie AN, Sharaf MHN, Schiff PL, Boye GL, Crouch RC, Martin GE (1991). Assignment of the proton and carbon NMR spectra of the indoquinoline alkaloid cryptolepine. J. Heterocycl. Chem. 28: 1429-1435.
23. Wright CW, Philipson JD, Awe SO, Kirby GC, Warhurst DC, Quentin-Leclercq J, Angenot L (1996). Antimalarial action of cryptolepine and some other anhydronium bases. Phytother. Res. 10: 361-363.